Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
Author(s) -
Lawrence J. Appel,
Jackson T. Wright,
Tom Greene,
Lawrence Y. Agodoa,
Brad C. Astor,
George L. Bakris,
W. H. Cleveland,
Jeanne Charleston,
Gabriel Contreras,
Marquetta Faulkner,
Francis B. Gabbai,
Jennifer Gassman,
Lee A. Hebert,
Kenneth Jamerson,
Joel D. Kopple,
John W. Kusek,
James P. Lash,
Janice P. Lea,
Julia B. Lewis,
Michael S. Lipkowitz,
Shaul G. Massry,
Edgar R. Miller,
Keith C. Norris,
Robert A. Phillips,
Velvie A. Pogue,
Otelio S. Randall,
Stephen G. Rostand,
Miroslaw Smogorzewski,
Robert D. Toto,
Xuelei Wang
Publication year - 2010
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0910975
Subject(s) - medicine , kidney disease , blood pressure , observational study , disease , chronic renal disease , intensive care medicine , kidney
In observational studies, the relationship between blood pressure and end-stage renal disease (ESRD) is direct and progressive. The burden of hypertension-related chronic kidney disease and ESRD is especially high among black patients. Yet few trials have tested whether intensive blood-pressure control retards the progression of chronic kidney disease among black patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom